AVITA Medical Inc
RCEL3.620USD
-0.160-4.23%
收盘 11/04, 16:00（美东）报价延迟15分钟
96.34M总市值
亏损市盈率 TTM
关于 AVITA Medical Inc 公司
AVITA Medical, Inc. 是一家商业阶段再生医学公司。该公司是再生医学的提供商，致力于解决烧伤、全层皮肤缺损和白癜风等皮肤色素沉着方面尚未满足的医疗需求。其 RECELL 平台是一种一次性、独立、电池供电的自体细胞采集设备，包含酶和缓冲溶液、无菌手术器械和执行器。RECELL 用于治疗热烧伤伤口和全层皮肤缺损，以及对稳定的脱色白癜风病变进行色素沉着。RECELL 系统的平台技术能够处理和制备来自患者的薄层皮肤样本，产生一种称为喷雾皮肤细胞的自体细胞悬浮液。这些喷雾皮肤细胞在护理点只需 30 分钟即可制备完成，为治疗热烧伤伤口和全层皮肤缺损提供了一种新方法。
AVITA Medical Inc简介
公司代码RCEL
公司名称AVITA Medical Inc
上市日期Mar 18, 2012
CEOMr. James M. (Jim) Corbett
员工数量260
证券类型Ordinary Share
年结日Mar 18
公司地址28159 Avenue Stanford
城市VALENCIA
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编91355
电话16613679170
网址https://www.avitamedical.com/
公司代码RCEL
上市日期Mar 18, 2012
CEOMr. James M. (Jim) Corbett
AVITA Medical Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
暂无数据
地区USD
名称
营收
占比
United States
17.90M
97.17%
Japan
427.00K
2.32%
United Kingdom
55.00K
0.30%
Australia
40.00K
0.22%
European Union (Region)
0.00
0.00%
业务
地区
暂无数据
股东统计
更新时间: 8月17日 周日
更新时间: 8月17日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Investment Management (US)
1.99%
UBS Financial Services, Inc.
1.54%
其他
82.17%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Investment Management (US)
1.99%
UBS Financial Services, Inc.
1.54%
其他
82.17%
股东类型
持股股东
占比
Investment Advisor
16.21%
Investment Advisor/Hedge Fund
7.95%
Hedge Fund
3.40%
Research Firm
1.31%
Individual Investor
0.91%
Pension Fund
0.23%
Venture Capital
0.11%
Bank and Trust
0.10%
Insurance Company
0.03%
其他
69.75%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
206
7.81M
29.34%
-1.85M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
2023Q2
206
8.16M
32.08%
-1.08M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
1.74M
6.53%
+13.93K
+0.81%
Jun 30, 2025
The Vanguard Group, Inc.
1.45M
5.45%
+16.54K
+1.15%
Jun 30, 2025
Geode Capital Management, L.L.C.
618.34K
2.32%
-1.36K
-0.22%
Jun 30, 2025
State Street Investment Management (US)
528.78K
1.99%
+1.83K
+0.35%
Jun 30, 2025
UBS Financial Services, Inc.
409.80K
1.54%
+65.07K
+18.88%
Jun 30, 2025
Opaleye Management Inc.
389.52K
1.46%
-50.48K
-11.47%
Jun 30, 2025
Millennium Management LLC
369.19K
1.39%
+357.21K
+2980.45%
Jun 30, 2025
Northern Trust Investments, Inc.
242.03K
0.91%
-10.13K
-4.02%
Jun 30, 2025
Jacobs Levy Equity Management, Inc.
138.20K
0.52%
+92.23K
+200.61%
Jun 30, 2025
Wellington Management Company, LLP
110.70K
0.42%
+28.50K
+34.66%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
查看更多
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
iShares Micro-Cap ETF
占比0.01%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
ProShares UltraPro Russell2000
占比0%
iShares Russell 3000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
iShares Russell 2000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
Global X Russell 2000 ETF
占比0%
Direxion Daily S&P Biotech Bull 3X Shares
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
